The lyophilized injectable market is projected to grow from USD 3.8 billion in 2025 to USD 6.8 billion by 2035, at a CAGR of 6.0%. Single-Use Vials will dominate with a 48.6% market share, while prefilled diluent syringes will lead the type of delivery segment with a 42.9% share.